Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene related to the potassium inwardly-rectifying channel protein (subfamily J, member 12). As a pseudogene, ENSG00000263433 does not encode a functional protein and therefore does not serve as a receptor, channel, or other actionable therapeutic target. Pseudogenes typically arise from duplication or retrotransposition events and are generally nonfunctional remnants of once-active genes. There is no evidence for this pseudogene having a biological function, clinical relevance, or pharmacologic interactions. The functional potassium inwardly-rectifying channel, subfamily J, member 12 is known as KCNJ12 (not a pseudogene; gene ID ENSG00000184185), which encodes an actual ion channel. The pseudogene ENSG00000263433 does not produce a protein product and lacks functional or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium inwardly-rectifying channel, subfamily J, member 12 pseudogene.